BeStock  
Stocks › Biotechnology › TRVI

Trevi Therapeutics TRVI

US equityMarket cap rank #2802Biotechnology
$13.72 −$0.19 (-1.37%)
Pre-market · Oct 6, 4:10 am ET · After hours $13.72 0.00%
Open$13.97
Prev close$13.91
Day range$13.51 – $14.11
Volume1.72M
Market cap$1.95B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / book6.1x
CheapRich

Above its usual level · 64th percentile, 5-year average 4.7x

#4480 of 5315 stocks by PB (1 = cheapest)

Morningstar fair value estimate

Fair value$10.99
Price vs. fair value+24.8%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 6.08 – 4.67 64% (pricier than usual) #4480 of 5315 (1 = cheapest)
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$10.99
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on TRVI.

Leave a comment

Scroll to Top